Literature DB >> 25572033

2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.

Steven Z Pavletic1, Georgia B Vogelsang2, Stephanie J Lee3.   

Abstract

Mesh：

Year:  2015        PMID： 25572033     DOI： 10.1016/j.bbmt.2014.12.035

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  12 in total

1.  Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Christopher J Fraser; Smita Bhatia; Kirsten Ness; Andrea Carter; Liton Francisco; Mukta Arora; Pablo Parker; Stephen Forman; Daniel Weisdorf; James G Gurney; K Scott Baker
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

Review 2.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

Review 3.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

4.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

Authors:  Minoo Battiwalla; Shahrukh Hashmi; Navneet Majhail; Steven Pavletic; Bipin N Savani; Nonniekaye Shelburne
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-29       Impact factor: 5.742

5.  B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.

Authors:  R M Saliba; S Sarantopoulos; C L Kitko; A Pawarode; S C Goldstein; J Magenau; A M Alousi; T Churay; H Justman; S Paczesny; P Reddy; D R Couriel
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

6.  Syk and tired of current chronic GVHD therapies.

Authors:  Daniel H Fowler; Steven Z Pavletic
Journal:  Blood       Date:  2015-06-25       Impact factor: 22.113

Review 7.  Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.

Authors:  Erden Atilla; Pınar Ataca Atilla; Güldane Cengiz Seval; Mehmet Bektaş; Taner Demirer
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

Review 8.  Classification systems for chronic graft-versus-host disease.

Authors:  Stephanie J Lee
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

9.  Biomarker Panel for Chronic Graft-Versus-Host Disease.

Authors:  Jeffrey Yu; Barry E Storer; Kushi Kushekhar; Mohammad Abu Zaid; Qing Zhang; Philip R Gafken; Yuko Ogata; Paul J Martin; Mary E Flowers; John A Hansen; Mukta Arora; Corey Cutler; Madan Jagasia; Joseph Pidala; Betty K Hamilton; George L Chen; Iskra Pusic; Stephanie J Lee; Sophie Paczesny
Journal:  J Clin Oncol       Date:  2016-05-23       Impact factor: 44.544

Review 10.  Extracorporeal Photopheresis in Graft-versus-Host Disease.

Authors:  Beatrice Drexler; Andreas Buser; Laura Infanti; Gregor Stehle; Joerg Halter; Andreas Holbro
Journal:  Transfus Med Hemother       Date:  2020-05-19       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.